Paulash Mohsen Net Worth & Insider Trades

Paulash Mohsen - Chief Business Officer, Yumanity Therapeutics, Inc

As of February 7, 2022

What is Paulash Mohsen's Net Worth?

The current estimated net worth of Yumanity Therapeutics, Inc's Chief Business Officer, Paulash Mohsen, is estimated to be about $72.43K . Paulash Mohsen owns about 59,135 units of Yumanity Therapeutics, Inc common stock. In the last 2 years at Yumanity Therapeutics, Inc, Paulash Mohsen has sold an estimated value of $3.58K worth.

What is Paulash Mohsen's Past Insider Trading?

Paulash Mohsen's largest sale order was 1,958 units , worth over $3.58K on February 7, 2022. In total, Paulash Mohsen has made about 4 transactions over 2 years of their time at Yumanity Therapeutics, Inc. Paulash Mohsen usually trades in December and February, with the busiest year in 2021.

Attention insiders: Dive deeper into market movements and stay ahead of the curve with Benzinga Pro! From up-to-the-second news to audio squawks and interactive data tools, it's everything you need to supercharge your trading strategy. Experience the Benzinga Pro advantage today and transform the way you trade with our exclusive free trial!

Paulash Mohsen

Date Range: All Time
Ticker
Type
Value
Price per Share
Shares
Filing Date
No matching records found
Loading...

InsideArbitrage

Our partner InsideArbitrage provides a full suite of tools and analysis that allows you to find opportunities from the hundreds of insiders transactions filed by company insiders each week. The service includes the popular Insider Weekends articles that highlight the top 5 insider purchases and sales each week as well as detailed analysis of one company each week. The service also includes several custom screens such as the Double Dipper that includes a list of companies that are buying back their shares while their insiders are independently buying stock on the open market for their own portfolios.

What is Paulash Mohsen's' Mailing Address?

  • Mailing address is C/o Yumanity Therapeutics, Inc. 40 Guess Street Suite 4410 Boston MA 02135 MA

What are Yumanity Therapeutics, Inc's Past Insider Trades?

Yumanity Therapeutics, Inc's most recent insider trade came on December 6, 2022 by Richard Peters who sold 10,890 units worth $18.42K . In the last 11 months, insiders at Yumanity Therapeutics, Inc have sold an estimated value of $135.61K and bought an estimated value of $99.98K worth of shares. Insider trading is most common in December, with the busiest year in 2021. The most active traders at the company are Richard Peters, President and CEO,  Marie Epstein, Principal Accounting Officer,  and Devin W. Smith, SVP and General Counsel .

YUMANITY THERAPEUTICS, INC. Insider Trades

Date Range: All Time
Insider Names
Type
Value
Price per Share
Shares
Filing Date
No matching records found
Loading...